Dataset Open Access
Gündel, Daniel; Teodoro, Rodrigo; c, Friedrich-Alexander Ludwig a.; Heerklotz a., Anne; Toussaint, Magali; Deuther-Conrad, Winnie; Bormans d., Guy; Brust a., Peter; Kopka, Klaus; Moldovan, Rares-Petru; f, Rareş-Petru Moldovan
What is already known • Increased expression of the CB2R in the brain is linked to certain neuropathological diseases. • First clinical trials for CB2R-directed therapies are conducted. What this study adds • [18F]JHU94620-d8 provides the potential to quantify the CB2R receptor density in the brain by positron-emission-tomography. Clinical significance • Stratification of patients for CB2R-directed therapies and follow up of the treatment response is needed.
Name | Size | |
---|---|---|
18FJHU94620_gammacounter_results15Jan2020.xlsx
md5:55b39f77b300f1f1cbfdace12f5ea7cf |
15.4 kB | Download |
All versions | This version | |
---|---|---|
Views | 18 | 18 |
Downloads | 3 | 3 |
Data volume | 46.3 kB | 46.3 kB |
Unique views | 16 | 16 |
Unique downloads | 3 | 3 |